✦ LIBER ✦

Molecular Design and Characterization of an α-Thrombin Inhibitor Containing a Novel P1 Moiety

✍ Scribed by Malikayil, J. A.; Burkhart, Joseph P.; Schreuder, Herman A.; Broersma,, Robert J.; Tardif, Chantal; Kutcher, Louis W.; Mehdi, Shujaath; Schatzman, Gerald L.; Neises, Bernhard; Peet, Norton P.

Book ID: 120448079
Publisher: American Chemical Society
Year: 1997
Tongue: English
Weight: 170 KB
Volume: 36
Category: Article
ISSN: 0006-2960
DOI: 10.1021/bi9622231

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design and Characterization of a Seleniu

Design and Characterization of a Selenium-Containing Inhibitor of Activated Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa), a Zinc-Containing Metalloprotease

✍ Yoshimoto, Nobuko; Sasaki, Tomoyuki; Sugimoto, Katsuyoshi; Ishii, Hidemi; Yamamo 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 350 KB

Design, Synthesis, and Evolution of a No

Design, Synthesis, and Evolution of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors: P1-Argininal Derivatives Incorporating P3-P4 Lactam Sulfonamide Moieties 1

✍ Semple, J. Edward; Rowley, David C.; Brunck, Terence K.; Ha-Uong, Theresa; Minam 📂 Article 📅 1996 🏛 American Chemical Society 🌐 English ⚖ 348 KB

Design of Weakly Basic Thrombin Inhibito

Design of Weakly Basic Thrombin Inhibitors Incorporating Novel P1 Binding Functions: Molecular and X-ray Crystallographic Studies†

✍ De Simone, Giuseppina; Menchise, Valeria; Omaggio, Salvatore; Pedone, Carlo; Sco 📂 Article 📅 2003 🏛 American Chemical Society 🌐 English ⚖ 265 KB

Discovery of a Novel, Selective, and Ora

Discovery of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors Incorporating Aminopyridyl Moieties at the P1 Position

✍ Feng, Dong-Mei; Gardell, Stephen J.; Lewis, S. Dale; Bock, Mark G.; Chen, Zhongg 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 241 KB

ChemInform Abstract: Design, Synthesis,

ChemInform Abstract: Design, Synthesis, and Evolution of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors: P1-Argininal Derivatives Incorporating P3-P4 Lactam Sulfonamide Moieties.

✍ J. E. SEMPLE; D. C. ROWLEY; T. K. BRUNCK; T. HA-UONG; N. K. MINAMI; T. D. OWENS; 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 3 views

Design, synthesis, characterization and

Design, synthesis, characterization and in-vivo activity of a novel salmon calcitonin conjugate containing a novel PEG-lipid moiety

✍ Weiqiang Cheng; Lee-Yong Lim 📂 Article 📅 2010 🏛 Pharmaceutical Press 🌐 English ⚖ 444 KB